Pentraxin 2 (PRM-151)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 14:48, 17 September 2015 by Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism per [http://www.cancer.gov/publications/dictionaries/cancer-drug?CdrID=753252 NCI Drug Dictionary]: A fully recombinant form of the hum...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

General information

Class/mechanism per NCI Drug Dictionary: A fully recombinant form of the human pentraxin 2 (PTX2) protein with potential antifibrotic activity. Upon intravenous administration, recombinant human serum amyloid P/pentraxin 2 (PRM-151) may inhibit myofibroblast generation by preventing the differentiation of circulating monocytes into fibrocytes and profibrotic macrophages. PTX2 is a circulating plasma protein that belongs to the class of pattern recognition receptors (PRR) of the innate immune system.
Route: IV
Extravasation: n/a

Preliminary data

Myelofibrosis